NOW AVAILABLE: “XBOOM BY WILL.I.AM” WITH FYI.RAiDiO — THE SPEAKER THAT TALKS BACK
Culturally Rich AI DJs, Personalized Broadcasts, and New Signature Sound Redefine Portable Audio LOS ANGELES, Sept. 19, 2025 /PRNewswire/ — FYI.AI, the... Read more.
AMES WATSON TAKES OVER BUSINESS OPERATIONS OF CLAIRE’S IN NORTH AMERICA
Ames Watson will lead with a smaller but stronger footprint COLUMBIA, Md., Sept. 19, 2025 /PRNewswire/ — Ames Watson, a privately held investment firm with... Read more.
AZ-VC II Launches to Fill The Funding Gap For Non-Coastal Startups; Eschews Sky-High Coastal Valuations
Non-Coastal Venture Capital Firm AZ-VC Adds Second Vintage Vehicle to itsSuccessful $115 First Fund PHOENIX, Sept. 19, 2025 /PRNewswire/ — AZ-VC, a U.S. venture... Read more.
Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025
SHANGHAI and HONG KONG, Sept. 19, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene“, SEHK: 6996.HK), a leading innovative, commercial-stage... Read more.
Immutable Seizes $121B Opportunity with Launch of Mobile Gaming Division
SYDNEY, Sept. 19, 2025 /PRNewswire/ — Immutable, the global leader in gaming, today announced the launch of its Mobile Gaming Division, a specialist taskforce... Read more.
Elmo Motion Control Continues the North American 2025 Roadshow, with a Focus on Robotics
PETAH TIKVA, Israel, Sept. 19, 2025 /PRNewswire/ — Elmo Motion Control, a global technology leader in motion control solutions, is pleased to reveal its latest... Read more.
China Accelerates Progress on L2 Mandatory Standards, RoboSense Digital LiDAR Becomes the Safety Technology of Choice
SHENZHEN, China, Sept. 19, 2025 /PRNewswire/ — On September 17, 2025, the Ministry of Industry and Information Technology (MIIT) solicited public comments... Read more.
Pyxis Advisory Group Acquires Catule Consulting
Expanding Leadership to help clients navigate complex business transformations across energy and industrial markets HOUSTON, Sept. 19, 2025 /PRNewswire/ —... Read more.
FDA Grants Orphan Drug Designation to NS-051/NCNP-04 for the Treatment of Duchenne Muscular Dystrophy
PARAMUS, N.J., Sept. 19, 2025 /PRNewswire/ — NS Pharma, Inc. announced today that the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation... Read more.
Huawei Cloud: Empowering Customers to Succeed in Global Markets Through Continuous Innovation
SHANGHAI, Sept. 19, 2025 /PRNewswire/ — At HUAWEI CONNECT 2025, Charles Yang, Senior Vice President of Huawei and President of Huawei Cloud Global Marketing... Read more.